The global mouth ulcer treatment market size was estimated at USD 1.52 billion in 2022 and is projected to reach USD 2.06 billion by 2030, growing at a CAGR of 3.9% from 2023 to 2030. Rising awareness regarding oral hygiene and the increasing geriatric population are anticipated to drive... Read More »
August 2023The global narcolepsy therapeutics market size was estimated at USD 3.52 billion in 2023 and is expected to reach USD 6.01 billion by 2030, growing at a CAGR of 7.9% from 2024 to 2030. Narcolepsy is a lifelong sleep disorder with sudden uncontrollable sleep attacks and affects every... Read More »
August 2023The non-injectable insulin market comprises various insulin formulations designed for administration without injections. These alternatives offer options for individuals with diabetes who face challenges with conventional injection techniques or have allergies to injections. Non-injectab...Read More »
The growth of the global biosimilar monoclonal antibodies (mAbs) market can be attributed to various factors which include increasing patent expiries of monoclonal antibodies, advancements in mAbs innovation, increasing demand for cost-efficient products, the rising prevalence of chronic...Read More »
Cryptococcosis, caused by Cryptococcus neoformans and Cryptococcus gattii fungi, primarily affects individuals with weakened immune systems, including those with HIV/AIDS or who have undergone organ transplantation. The infection is typically acquired through inhaling dust containing yea...Read More »
The generation of alpha-1 antitrypsin (AAT) protein in the liver is impacted by alpha-1 antitrypsin deficiency (AATD), a hereditary condition. The lungs' defense against harm from enzymes generated during inflammation is provided by AAT. Lung and liver disorders can result from low amoun...Read More »
Over-the-counter (OTC) analgesics are easily accessible medications purchased without a prescription to relieve pain and reduce fever. They are commonly used for mild to moderate pain symptoms like headaches, muscle aches, toothaches, menstrual cramps, and minor injuries. OTC analgesics ...Read More »
The pharmaceutical sector's emphasis on creating and manufacturing drugs exclusively for infants, kids, and teenagers with an aim of early diagnosis and treatment is expected to propel the market. By taking into account variables including age, weight, metabolism, and developmental stage...Read More »
The global dupuytren’s disease market size was estimated at USD 4.13 billion in 2022 and is expected to reach USD 5.87 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.55% from 2023 to 2030. The projected growth is attributed to the increasing prevalence and ad... Read More »
July 2023The North America maternal mental health market size was estimated at USD 2.61 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 29.68% from 2023 to 2030. The rise in government funding to reduce maternal mortality, increasing incidence of post-partum de... Read More »
July 2023The global maternal mental health size was estimated at USD 6,219.3 million in 2022 and is projected to reach USD 45,724.3 million by 2030, growing at a CAGR of 28.3% from 2023 to 2030... Read More »
July 2023The global glaucoma market size was estimated at USD 8.03 billion in 2022 and is projected to reach USD 11.52 billion by 2030, growing at a CAGR of 4.61% from 2023 to 2030. Some of the major factors influencing market expansion are the rising incidences of glaucoma and the increasing demand for innovative thera... Read More »
July 2023The Europe parenteral lipid emulsion market size was worth USD 640.9 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2030. Growing incidence of hospital malnutrition, the rising prevalence of cancer, gastrointestinal disorders, and ... Read More »
July 2023The global sustained release excipients market size was estimated at USD 1.26 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030. The market growth has been largely influenced by increasing number of patent expirations and the growin... Read More »
June 2023The global alzheimer’s therapeutics market size was estimated at USD 4.05 billion in 2022 and is anticipated to reach USD 15.19 billion by 2030, growing at a CAGR of 19.99% from 2023 to 2030. The rising prevalence of Alzheimer’s Disease (AD) and approval of disease-modifying ... Read More »
June 2023The Arizona legal cannabis market size was valued at USD 1.26 billion in 2023 and is expected to grow at a CAGR of 14.4% from 2024 to 2030. Increasing burden of chronic pain and rising demand for effective pain management therapies are boosting the growth of the market. Moreover, rising ... Read More »
June 2023The North America alopecia market size was valued at USD 2.88 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. The increasing prevalence of alopecia coupled with the rising prevalence of autoimmune and other chronic disorders that... Read More »
June 2023(CAGR) of 15.3% from 2023 to 2030. The growth of the U.S. cannabinoids industry is attributed to the increasing use of cannabinoids for the rising awareness about their health and therapeutic benefits... Read More »
June 2023The global analgesics market size was valued at USD 38.60 billion in 2022 and is projected to reach USD 61.39 billion by 2030, growing at a CAGR of 6.02% from 2023 to 2030. Increasing incidences of arthritis & osteoarthritis, neuropathic diseases, and cancer are expected to boos... Read More »
June 2023The California legal cannabis market size was valued at USD 5.37 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2030. The growth is attributed to the rising awareness regarding the use of cannabis products for pain management therapies. According to a study ... Read More »
May 2023